This study tests whether adding an experimental drug (BRII-835) to standard interferon therapy can better control chronic hepatitis B. About 86 adults on antiviral pills will receive either interferon alone or with different doses of BRII-835. The goal is to see if the combinatio…
Phase: PHASE2 • Sponsor: Brii Biosciences Limited • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC